Global T Cell Specific Surface Glycoprotein CD28 Market Growth 2024-2031

Report ID: 1503531 | Published Date: Feb 2026 | No. of Page: 96 | Base Year: 2025 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for T Cell Specific Surface Glycoprotein CD28 by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for T Cell Specific Surface Glycoprotein CD28 by Country/Region, 2017, 2022 & 2028
    2.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type
        2.2.1 FPT-155
        2.2.2 FR-104
        2.2.3 Lulizumab Pegol
        2.2.4 Others
    2.3 T Cell Specific Surface Glycoprotein CD28 Sales by Type
        2.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
        2.3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2017-2022)
        2.3.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Type (2017-2022)
    2.4 T Cell Specific Surface Glycoprotein CD28 Segment by Application
        2.4.1 Plaque Psoriasis
        2.4.2 Solid Tumor
        2.4.3 Acute Renal Failure(ARF)
        2.4.4 Others
    2.5 T Cell Specific Surface Glycoprotein CD28 Sales by Application
        2.5.1 Global T Cell Specific Surface Glycoprotein CD28 Sale Market Share by Application (2017-2022)
        2.5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Application (2017-2022)
        2.5.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Application (2017-2022)
3 Global T Cell Specific Surface Glycoprotein CD28 by Company
    3.1 Global T Cell Specific Surface Glycoprotein CD28 Breakdown Data by Company
        3.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Company (2020-2022)
        3.1.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Company (2020-2022)
    3.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Company (2020-2022)
        3.2.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2020-2022)
        3.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company (2020-2022)
    3.3 Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Company
    3.4 Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Location Distribution
        3.4.2 Players T Cell Specific Surface Glycoprotein CD28 Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for T Cell Specific Surface Glycoprotein CD28 by Geographic Region
    4.1 World Historic T Cell Specific Surface Glycoprotein CD28 Market Size by Geographic Region (2017-2022)
        4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Geographic Region
    4.2 World Historic T Cell Specific Surface Glycoprotein CD28 Market Size by Country/Region (2017-2022)
        4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Annual Sales by Country/Region (2017-2022)
        4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue by Country/Region
    4.3 Americas T Cell Specific Surface Glycoprotein CD28 Sales Growth
    4.4 APAC T Cell Specific Surface Glycoprotein CD28 Sales Growth
    4.5 Europe T Cell Specific Surface Glycoprotein CD28 Sales Growth
    4.6 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Growth
5 Americas
    5.1 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country
        5.1.1 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022)
        5.1.2 Americas T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022)
    5.2 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Type
    5.3 Americas T Cell Specific Surface Glycoprotein CD28 Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region
        6.1.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region (2017-2022)
        6.1.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2017-2022)
    6.2 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Type
    6.3 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe T Cell Specific Surface Glycoprotein CD28 by Country
        7.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022)
        7.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022)
    7.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type
    7.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 by Country
        8.1.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022)
        8.1.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022)
    8.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type
    8.3 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28
    10.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
    10.4 Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 T Cell Specific Surface Glycoprotein CD28 Distributors
    11.3 T Cell Specific Surface Glycoprotein CD28 Customer
12 World Forecast Review for T Cell Specific Surface Glycoprotein CD28 by Geographic Region
    12.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Region
        12.1.1 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Region (2023-2028)
        12.1.2 Global T Cell Specific Surface Glycoprotein CD28 Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Type
    12.7 Global T Cell Specific Surface Glycoprotein CD28 Forecast by Application
13 Key Players Analysis
    13.1 Atox Bio Ltd
        13.1.1 Atox Bio Ltd Company Information
        13.1.2 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Offered
        13.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Atox Bio Ltd Main Business Overview
        13.1.5 Atox Bio Ltd Latest Developments
    13.2 Bristol-Myers Squibb Co
        13.2.1 Bristol-Myers Squibb Co Company Information
        13.2.2 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Offered
        13.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Bristol-Myers Squibb Co Main Business Overview
        13.2.5 Bristol-Myers Squibb Co Latest Developments
    13.3 Five Prime Therapeutics Inc
        13.3.1 Five Prime Therapeutics Inc Company Information
        13.3.2 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Offered
        13.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Five Prime Therapeutics Inc Main Business Overview
        13.3.5 Five Prime Therapeutics Inc Latest Developments
    13.4 Johnson & Johnson
        13.4.1 Johnson & Johnson Company Information
        13.4.2 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Offered
        13.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Johnson & Johnson Main Business Overview
        13.4.5 Johnson & Johnson Latest Developments
    13.5 TheraMAB LLC
        13.5.1 TheraMAB LLC Company Information
        13.5.2 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Offered
        13.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 TheraMAB LLC Main Business Overview
        13.5.5 TheraMAB LLC Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. T Cell Specific Surface Glycoprotein CD28 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. T Cell Specific Surface Glycoprotein CD28 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of FPT-155
    Table 4. Major Players of FR-104
    Table 5. Major Players of Lulizumab Pegol
    Table 6. Major Players of Others
    Table 7. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2017-2022) & (K Pcs)
    Table 8. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
    Table 9. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2017-2022) & ($ million)
    Table 10. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2017-2022)
    Table 11. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 12. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2017-2022) & (K Pcs)
    Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Table 14. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2017-2022)
    Table 15. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2017-2022)
    Table 16. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 17. Global T Cell Specific Surface Glycoprotein CD28 Sales by Company (2020-2022) & (K Pcs)
    Table 18. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Company (2020-2022)
    Table 19. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company (2020-2022)
    Table 21. Global T Cell Specific Surface Glycoprotein CD28 Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 22. Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Producing Area Distribution and Sales Area
    Table 23. Players T Cell Specific Surface Glycoprotein CD28 Products Offered
    Table 24. T Cell Specific Surface Glycoprotein CD28 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global T Cell Specific Surface Glycoprotein CD28 Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 28. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Geographic Region (2017-2022)
    Table 29. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global T Cell Specific Surface Glycoprotein CD28 Sales by Country/Region (2017-2022) & (K Pcs)
    Table 32. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country/Region (2017-2022)
    Table 33. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022) & (K Pcs)
    Table 36. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2017-2022)
    Table 37. Americas T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2017-2022)
    Table 39. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Type (2017-2022) & (K Pcs)
    Table 40. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
    Table 41. Americas T Cell Specific Surface Glycoprotein CD28 Sales by Application (2017-2022) & (K Pcs)
    Table 42. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Table 43. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Region (2017-2022) & (K Pcs)
    Table 44. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2017-2022)
    Table 45. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2017-2022)
    Table 47. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Type (2017-2022) & (K Pcs)
    Table 48. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
    Table 49. APAC T Cell Specific Surface Glycoprotein CD28 Sales by Application (2017-2022) & (K Pcs)
    Table 50. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Table 51. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022) & (K Pcs)
    Table 52. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2017-2022)
    Table 53. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2017-2022)
    Table 55. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2017-2022) & (K Pcs)
    Table 56. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
    Table 57. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2017-2022) & (K Pcs)
    Table 58. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2017-2022) & (K Pcs)
    Table 60. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2017-2022) & (K Pcs)
    Table 64. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2017-2022) & (K Pcs)
    Table 66. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of T Cell Specific Surface Glycoprotein CD28
    Table 68. Key Market Challenges & Risks of T Cell Specific Surface Glycoprotein CD28
    Table 69. Key Industry Trends of T Cell Specific Surface Glycoprotein CD28
    Table 70. T Cell Specific Surface Glycoprotein CD28 Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. T Cell Specific Surface Glycoprotein CD28 Distributors List
    Table 73. T Cell Specific Surface Glycoprotein CD28 Customer List
    Table 74. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 75. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Forecast by Region
    Table 76. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 79. Americas T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 81. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 83. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 85. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 87. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 91. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Atox Bio Ltd Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
    Table 95. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Offered
    Table 96. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 97. Atox Bio Ltd Main Business
    Table 98. Atox Bio Ltd Latest Developments
    Table 99. Bristol-Myers Squibb Co Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
    Table 100. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Offered
    Table 101. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 102. Bristol-Myers Squibb Co Main Business
    Table 103. Bristol-Myers Squibb Co Latest Developments
    Table 104. Five Prime Therapeutics Inc Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
    Table 105. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Offered
    Table 106. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 107. Five Prime Therapeutics Inc Main Business
    Table 108. Five Prime Therapeutics Inc Latest Developments
    Table 109. Johnson & Johnson Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
    Table 110. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Offered
    Table 111. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 112. Johnson & Johnson Main Business
    Table 113. Johnson & Johnson Latest Developments
    Table 114. TheraMAB LLC Basic Information, T Cell Specific Surface Glycoprotein CD28 Manufacturing Base, Sales Area and Its Competitors
    Table 115. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Offered
    Table 116. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 117. TheraMAB LLC Main Business
    Table 118. TheraMAB LLC Latest Developments
List of Figures
    Figure 1. Picture of T Cell Specific Surface Glycoprotein CD28
    Figure 2. T Cell Specific Surface Glycoprotein CD28 Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of FPT-155
    Figure 10. Product Picture of FR-104
    Figure 11. Product Picture of Lulizumab Pegol
    Figure 12. Product Picture of Others
    Figure 13. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2021
    Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2017-2022)
    Figure 15. T Cell Specific Surface Glycoprotein CD28 Consumed in Plaque Psoriasis
    Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Market: Plaque Psoriasis (2017-2022) & (K Pcs)
    Figure 17. T Cell Specific Surface Glycoprotein CD28 Consumed in Solid Tumor
    Figure 18. Global T Cell Specific Surface Glycoprotein CD28 Market: Solid Tumor (2017-2022) & (K Pcs)
    Figure 19. T Cell Specific Surface Glycoprotein CD28 Consumed in Acute Renal Failure(ARF)
    Figure 20. Global T Cell Specific Surface Glycoprotein CD28 Market: Acute Renal Failure(ARF) (2017-2022) & (K Pcs)
    Figure 21. T Cell Specific Surface Glycoprotein CD28 Consumed in Others
    Figure 22. Global T Cell Specific Surface Glycoprotein CD28 Market: Others (2017-2022) & (K Pcs)
    Figure 23. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2017-2022)
    Figure 24. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application in 2021
    Figure 25. T Cell Specific Surface Glycoprotein CD28 Revenue Market by Company in 2021 ($ Million)
    Figure 26. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2021
    Figure 27. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Geographic Region (2017-2022)
    Figure 28. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Geographic Region in 2021
    Figure 29. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2017-2022)
    Figure 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country/Region in 2021
    Figure 31. Americas T Cell Specific Surface Glycoprotein CD28 Sales 2017-2022 (K Pcs)
    Figure 32. Americas T Cell Specific Surface Glycoprotein CD28 Revenue 2017-2022 ($ Millions)
    Figure 33. APAC T Cell Specific Surface Glycoprotein CD28 Sales 2017-2022 (K Pcs)
    Figure 34. APAC T Cell Specific Surface Glycoprotein CD28 Revenue 2017-2022 ($ Millions)
    Figure 35. Europe T Cell Specific Surface Glycoprotein CD28 Sales 2017-2022 (K Pcs)
    Figure 36. Europe T Cell Specific Surface Glycoprotein CD28 Revenue 2017-2022 ($ Millions)
    Figure 37. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales 2017-2022 (K Pcs)
    Figure 38. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue 2017-2022 ($ Millions)
    Figure 39. Americas T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2021
    Figure 40. Americas T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2021
    Figure 41. United States T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Canada T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 45. APAC T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region in 2021
    Figure 46. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions in 2021
    Figure 47. China T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Japan T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 49. South Korea T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 51. India T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Australia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2021
    Figure 54. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2021
    Figure 55. Germany T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 56. France T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 57. UK T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Italy T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Russia T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2021
    Figure 61. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2021
    Figure 62. Egypt T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 63. South Africa T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Israel T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 66. GCC Country T Cell Specific Surface Glycoprotein CD28 Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28 in 2021
    Figure 68. Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
    Figure 69. Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28
    Figure 70. Channels of Distribution
    Figure 71. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global T Cell Specific Surface Glycoprotein CD28 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global T Cell Specific Surface Glycoprotein CD28 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global T Cell Specific Surface Glycoprotein CD28 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports